Vergoeding 2015-2019 voor ATC-subgroep R03BB : Parasympathicolytica
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| R03BB01 Ipratropium (Atrovent ®) | 3.992.200 | 3.530.700 | 3.399.200 | 3.204.100 | 3.035.500 |
| R03BB04 Tiotropium (Spiriva ®) | 85.268.100 | 79.932.800 | 72.642.600 | 64.075.500 | 58.985.100 |
| R03BB05 Aclidiniumbromide (Eklira ®) | 1.497.000 | 1.551.100 | 1.437.200 | 1.375.100 | 1.252.300 |
| R03BB06 Glycopyrroniumbromide (Seebri breezhaler ®) | 2.896.100 | 2.673.000 | 2.379.400 | 2.101.800 | 1.818.500 |
| R03BB07 Umeclidiniumbromide (Incruse ellipta ®) | 39.098 | 223.560 | 505.870 | 649.030 | 689.140 |
| Totaal | 93.692.498 | 87.911.160 | 80.364.270 | 71.405.530 | 65.780.540 |